SBI launches pre-approved 2-wheeler loan ‘SBI Easy Ride’ on YONO, BFSI News, ET BFSI

[ad_1]

Read More/Less


State Bank of India has announced the launch of a pre-approved 2-wheeler loan scheme ‘SBI Easy Ride’ on its mobile banking app YONO. Eligible customers can apply for the loan through the app for an amount up to Rs. 3 lakhs, at a competitive interest rate of 10.5% per annum onwards, for a maximum tenure of four years.

“We believe this digital loan offering would help customers in buying their chosen two-wheeler. The product will also position the bank at the initial stage of a customer’s life cycle by offering a two-wheeler loan, and thereafter upgrade the relationship along with their growth,” chairman Dinesh Khara said.

The minimum loan amount has been fixed at Rs 20,000. The loan availed will be disbursed directly into the dealer’s account, and loans of up to 85% of the on-road price of the vehicle can be availed under this scheme.

Since its launch in 2017, YONO has more than 42 million registered users, and the bank has partnered with over 110 e-commerce players in more than 20 categories.



[ad_2]

CLICK HERE TO APPLY

Bank of Baroda signs MoU with NCDEX e-Markets

[ad_1]

Read More/Less


Bank of Baroda has signed a Memorandum of Understanding (MoU) with NCDEX e Markets Ltd (NEML) to become a “clearing bank” for handling financial transactions in the NeML market place and procurement/auction platform.

NEML, a wholly-owned subsidiary of agricultural commodity exchange, NCDEX, is an online commodities spot market and services company.

Jagdish Tungaria, Zonal Head, Mumbai, BoB, said: “This tie-up opens up multiple opportunities for both institutions. The bank will partner with agriculture marketing federations and other procurement agencies across the country and increase its presence in agri e-commerce through its wide network across the country.

Mrugank Paranjape, MD and CEO, NEML, said this tie-up will help NeML members across the country to further their agriculture businesses.

[ad_2]

CLICK HERE TO APPLY

Reserve Bank of India – Press Releases

[ad_1]

Read More/Less


I. T-Bill 91 days 182 days 364 days
II. Total Face Value Notified ₹10,000 Crore ₹3,000 Crore ₹7,000 Crore
III. Cut-off Price and Implicit Yield at Cut-Off Price 99.0985
(YTM: 3.6488%)
98.1030
(YTM: 3.8780%)
96.0811
(YTM: 4.0899%)
IV. Total Face Value Accepted ₹10,000 Crore ₹3,000 Crore ₹7,000 Crore

Ajit Prasad
Director   

Press Release: 2021-2022/1135

[ad_2]

CLICK HERE TO APPLY

HDFC Stock Retained On ‘Buy’ By ICICI Securities, HDFC’s NII Increased 18.4% YoY

[ad_1]

Read More/Less


Personal Finance

oi-Kuntala Sarkar

|

ICICI Securities has retrained the buy rating on HDFC, with a target price of Rs. 3350 per share. HDFC’s share price has increased more than 2x in the last 5 years. The brokerage firm has mentioned that the market leadership, funding advantage, and adequate capital have led them to remain positive on the company’s fundamentals. ICICI Securities has valued HDFC Ltd at ~2.5x FY23E core ABV.

HDFC Stock Retained On 'Buy' By ICICI Securities

Q2FY22 financial report of HDFC

In the latest Q2FY22 financial report, HDFC, the private lender has reported a steady operational show. Their loan growth stood at 9.6% YoY, and Individual loans were up 15.4% YoY. Significantly, the lender’s Net Interest Income (NII) increased 18.4% YoY, while NIMs went down 10 bps QoQ, dividends boost other income. On the other hand, the company’s GNPA went south 24 bps QoQ to 2.0%, which is a positive note for HDFC.

Key triggers for future price-performance

According to ICICI Securities, pick up in business growth with a turnaround in real estate market is positive, funding advantage and adequate capital to aid growth and earnings, healthy provision buffer and improvement in the collection to aid asset quality, and improved performance from subsidiaries to add value – will be the key triggers for future price performance.

About HDFC’s company stock

HDFC is the largest NBFC engaged in the housing finance business with a consistently good performance in terms of both business growth, and asset quality. Individual loans contribute ~78% of AUM of the company.

Rating rational of ICICI Securities is mentioned below

Buy: >15%
Hold: -5% to 15%;
Reduce: -15% to -5%
Sell:

(Check company stocks here.)

Disclaimer:

The above stock was picked from the brokerage report of ICICI Direct. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.

Story first published: Tuesday, November 2, 2021, 13:47 [IST]



[ad_2]

CLICK HERE TO APPLY

We remain optimistic on growth, says ICICI Lombard CEO

[ad_1]

Read More/Less


With the merger of Bharti AXA’s non-life business complete, ICICI Lombard General Insurance is excited about the business opportunities it has brought. In an interview with BusinessLine, Bhargav Dasgupta, Managing Director and CEO, ICICI Lombard outlines plans for the company post the second wave of the pandemic. Excerpts:

What is the strategy for the second half of the fiscal, especially with the merger of Bharti AXA’s non-life business?

We remain optimistic. For us the focus was in terms of getting the integration done. We got the approval and we had three working days to make it effective. It has gone smoothly. We are now working as a team. The reorganisation also has happened. Apart from that, there are a lot of business opportunities that we remain confident about. We believe health will be a big opportunity, we think motor will come back, and our corporate lines are doing well.

What’s the roadmap going forward post the Bharti AXA transaction?

Bharti AXA’s non-life business is around 20 per cent of our size as a company. As part of the transaction, we diluted about 7.3 per cent of our company. There are two things that we are looking at in terms of business, apart from people integration. One is the operational synergies. Over the last 12 months since we announced the deal, we’ve done a lot of preparatory work. Next three-to-six months we want to implement some of those things. The second is the revenue synergy and that is visible in terms of our quarterly numbers. We believe there is an even bigger opportunity with their distributors to give them new products. Some of these partners can sell more products in more markets. There is a scope for growth.

Are you re-entering the crop insurance segment?

We are already back in crop insurance because Bharti AXA was writing crop insurance. We will have the crop business, but as a percentage of our overall business, it may be relatively low. For the whole year, it will be about five per cent of our business. We want to stay invested and see how it goes for a couple of years before we take a decision on it.

We had a concern in crop insurance at two levels — one the reinsurance terms became very unfavourable. The underwriting aggression was also a bit high. And some of the challenges were in terms of the ground level implementation of the scheme on the crop cutting. Now, improvements has happened on all of these, so we’ll have to observe it.

As an industry, we are paying 18 per cent GST for health insurance, which is extremely high compared to global standards. The GST rate could be reduced to 5 or 12 per cent Bhargav Dasgupta MD and CEO ICICI Lombard

Motor segment continues to be very weak right now. Is that a concern?

There is an interesting dichotomy in motor, which has three components – private car, two-wheeler and commercial vehicles. In private cars, there is demand but there are supply-side constraints in terms of chip shortage.

On the two-wheeler, there is no supply-side issue but there seems to be a demand constraint at this point in time. It’s very unusual. We are hopeful that this festival season, the two-wheeler demand will pick up.

Motor third-party insurance rates have not increased. Is that another concern?

That is of course a concern because typically, the regulator would look at the actuarial data and give a price increase every year. It had issued an exposure draft in February-March of 2020, which had talked about a price increase about 7-8 per cent on a portfolio basis. That did not take place because of the pandemic-induced lockdown. This year, again, we had the second wave, so there was no price increase. In the meantime, there have been some judgments from the Supreme Court, which has increased the cost of claims. It’s an area of concern. We as an industry, need a price increase.

Any wish list for the Budget?

One wish list is for the budget, the other is for the GST Council. As an industry, we are paying 18 per cent GST for health insurance, which is extremely high compared to global standards. The GST rate could be reduced to 5 or 12 per cent. It’s been reduced to 12 per cent for commercial motor policy. Something similar on the health will be one ask that the industry has had for a long time. And a linked issue is the input credit for corporates as when they buy health insurance, they also don’t get that benefit.

On the Budget, we respect the fact that there are a lot of fiscal constraints and that the Finance Minister wants to streamline the personal benefits. But within the benefit pool that is there, if there could be some increase for health insurance and something for home insurance, in terms of tax breaks. It won’t be very expensive for the exchequer, but it will be a good nudge for people to buy insurance.

[ad_2]

CLICK HERE TO APPLY

Stocks To Pay Out Final Dividend In November 2021

[ad_1]

Read More/Less


1. P&G Health:

The stock of pharmaceuticals shall turn ex-dividend on November 2, 2021. The company declared Rs. 40 as its final dividend. Also, the company has declared special dividend, for which too the ex-date is November 2, 2021.

P&G Health was established as one of Merck’s Asia subsidiaries in the year 1967. In 2018, the company acquired Merck’s Consumer Health business. Procter & Gamble

Overseas India B.V. now holds 51.81% of the share capital in Merck Limited, while the remaining 48.19% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.

The stock of the company last traded at a price of Rs. 5503.65 per share.

2. P&G Hygiene:

2. P&G Hygiene:

The company is among the leading fast moving consumer goods company in India. For its final dividend of Rs. 80, the stock shall turn ex-dividend on November 9, 2021. This dividend has been declared for the financial year ended June 30, 2021.

The renowned brand under the company’s banner include women hygiene brand- Whisper, vicks and Old Spice.

4. Jai Corp:

4. Jai Corp:

The steel company is slated to announce its Q2Fy22 earnings today and the company has announced dividend (final) of Rs. 0.5 per share. For this dividend ex-date is November 12, 2021. Notably, ex-date is the date when you should be holding the shares in your demat for being eligible to be considered for the dividend payment or you should have sold shares on this date.

Incorporated in 1985, the company is into manufacturing like that of steel, plastic processing and spinning yarn. Apart from expansion of its plastic processing business, it is now focusing and investing in emerging opportunities like developing SEZs, infrastructure, venture capital and real estate. It is listed on Bombay Stock Exchange and National Stock Exchange.

5. Gillette India:

5. Gillette India:

The personal care company has announced a final dividend of Rs. 36 for the fiscal year 2021. For the june quarter the company’s income from operations came in at Rs.435.98 crore. Net profit for the financial year is at Rs. 27.5 crore.

The company’s stock price has been at Rs. 5820 per share.

Gillette India is in the business of manufacturing Blades and Razors, Oral care and Portable Power. Company has created brands like Duracell, Oral-B, MACH3 Turbo and 7oclock. .The company also in the business activities of Grooming, Oral Care, Portable Power



[ad_2]

CLICK HERE TO APPLY

Private banks’ NPAs fall in Q2 as economy charts recovery path, BFSI News, ET BFSI

[ad_1]

Read More/Less


With the economy opening up, the asset quality of private banks improved in the September quarter. Further, banks efforts in reducing slippages, improved collections, better recoveries from written off accounts and RBI mandated loans recast also helped banks keep a lid on NPAs.

While the year on year NPA figures of most banks were higher than the last quarter’s figures, they are not comparable as after the Supreme Court‘s stay on classifying loans that were standard as on August 31 from NPAs banks had reported NPAs under proforma figures.

The drop

HDFC Bank, India’s largest private sector lender, reported a drop in gross non-performing assets (GNPAs) to Rs 16,346 crore during July-September against Rs 17,099 crore in the preceding quarter. Provisions and contingencies also dropped to Rs 3,924.70 crore during the quarter compared with Rs 4,830.84 crore in the June quarter. GNPA ratio fell to 1.35 per cent as of September from 1.47 per cent in the June quarter. It was 1.08 per cent in the same quarter, a year ago.

ICICI Bank‘s gross non-performing assets fell to 4.82 per cent of gross advances as on September 30, against 5.15 per cent in the June quarter. Net NPAs (bad loans) also fell to 0.99 per cent from 1.16 per cent sequentially in the September quarter.

Federal Bank‘s asset quality improved on a sequential basis as gross NPA came at 3.24% as against 3.50% in the previous quarter. Its net NPA stood at 1.12% from 1.23% quarter-on-quarter (QoQ). However, the gross NPA during the year-ago quarter stood at 2.84% whereas net NPA at 0.99%. Provisions (other than tax) and contingencies declined to Rs 245 crore as against Rs 543 crore in the previous quarter and Rs 532 crore in the year-ago quarter.

Axis Bank and Kotak Bank

Axis Bank’s gross NPAs came in at 3.53% in the second quarter, lower than 3.85% in the June quarter and 4.18% in the previous year period. Meanwhile, the net NPA ratio during the quarter stood at l.08%.

Kotak Mahindra Bank’s gross NPAs during the second quarter stood at 3.19% compared with 3.56% in the June quarter. However, it was higher than 2.70% in the year-ago quarter. Meanwhile, the net NPA improved to 1.06% versus 1.28% on a sequential basis, and remained flat on a year-on-year basis.

What Crisil says

GNPAs of banks will rise to 8-9 per cent this fiscal, well below the peak of 11.2 per cent seen at the end of fiscal 2018, with the COVID-19 relief measures such as restructuring dispensation, and the Emergency Credit Line Guarantee Scheme (ECLGS) helping limit the rise, according to CRISIL Ratings.

GNPAs as at March-end 2021 had declined to 7.5 per cent against 8.2 per cent as at March-end 2020.

With about 2 per cent of bank credit expected under restructuring by the end of this fiscal, stressed assets ― comprising gross NPAs and loan book under restructuring ― should touch 10-11 per cent (against March-end 2021 estimate of about 9 per cent), the credit rating agency said.



[ad_2]

CLICK HERE TO APPLY

2 Cement Stocks To Buy According To ICICI Securities For Gains Up To 28%

[ad_1]

Read More/Less


JK Lakshmi Cement

In a 12-month target period, the brokerage has set a target price of Rs 785 on JK Lakshmi Cement, signifying a potential upside of up to 28 percent over the current market price of Rs 620.55. However, at the time of the buy call of the brokerage, the market price was Rs 615.

Q2FY22 Results:

“Owing to volume letdown and increased cost pressure, the results stayed poor. Revenues were up 7% to Rs 1118.2 crores led by sales realization growth of 10.3% YoY to Rs 4,820. Sales volume was down 2.9% YoY to 2.32 MT. EBITDA/t was down 10.3% YoY to Rs 701/t (vs. I-direct estimate of Rs 738/t). EBITDA margin was at 14.5%, down 333 bps YoY, 301bps QoQ. PAT of Rs 76.6 crore was down 5% YoY vs. (lower than the estimate of the brokerage: Rs 82.4 crore)” according to ICICI Securities.

Key triggers for future price-performance according to the brokerage:

  • With expected utilisation of 94%+ for FY22E, volume growth to moderate going forward as the new capacity will come on stream only in FY24E.
  • WHRS of 10 MW to get commissioned by Q3FY22 that should help contain power cost.
  • B/s strength to remain strong despite newly announced Capital Expenditure (CAPEX) of ~ Rs 1400 crore for its subsidiary unit UCWL.

Target Price and Valuation:

JK Lakshmi’s share price has grown by ~2.5x over the past three years (from ~ Rs 331 in August 2018 to Rs 816 in July 2021). We value the company at Rs 785 i.e.10x FY23E EV/EBITDA and we remain positive on the company and maintain BUY rating, said the brokerage.

“While the company may remain laggard in terms of growth during FY21-23E due to delayed capacity expansion (likely commissioning Q3FY24E), the focus on strengthening b/s with significant debt reduction in FY22E remains key positive. Given constructive sector outlook, we maintain the positive stance of the company and retain our BUY rating with revised TP of Rs 785/share (@ 10x FY23EV/EBITDA),” the brokerage has said.

Shree Cement

Shree Cement

The brokerage has set a target price of Rs 34,500 on Shree Cement stock, implying a potential upside of up to 18% over the current market price of Rs 29,220 in an estimated period of 12 months. Nevertheless, the market price at the time of the brokerage’s buy call was Rs 29,150.

Q2FY22 Results:

“Revenues were up 5% YoY on sustained higher realisations. Volumes were down 3.6% YoY on heavy monsoon and transporters strike in the east. EBITDA/t of Rs 1427/t (down 7.5% YoY) remained ahead of our estimates and PAT was up 5.6% YoY to Rs 577.7 Crore on lower tax, higher other income” said ICICI Securities.

Key triggers for future price performance according to the brokerage:

  • Commissioning of a grinding unit of 3 MT in Maharashtra to take its domestic capacity to over 46.4 MT. The new clinker unit in Chhattisgarh (capacity of 12000t/day) to get commissioned by Q4FY22 (Capital Expenditure (CAPEX) of Rs Rs 1000 crore)
  • New CAPEX includes setting up of a new integrated unit with 3.5 MT GU and 3.8 MT clinker unit in Rajasthan, 3 MT grinding unit in WB, 106 MW solar power at various locations with a total CAPEX of Rs 4750 crore till FY24E. Total domestic capacity to reach 53.4 MT post these expansions.
  • The company will continue to maintain its cost leadership due to the structural advantage it has in terms of accessing raw materials and markets.
  • The recent price hikes of 7-9% in October 2021 to sustain on the back of healthy demand and help recoup margins, to some extent.

Target Price and Valuation:

With volume-led expected revenue CAGR of 18.7% and expected RoCE of 20%+, we remain positive on the company. Hence maintain BUY rating and we value Shree at Rs 34,500 i.e.22x FY23E EV/EBITDA said the brokerage. “Cost leadership, a strong presence in north & east along with robust balance sheet justifies premium valuations, ICICI Securities further added.

Disclaimer

Disclaimer

The above stocks are picked from the brokerage report of ICICI Direct. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

LIC’s Jeevan Akshay Pension Policy With Multiple Annuity Options

[ad_1]

Read More/Less


Insurance

oi-Kuntala Sarkar

|

LIC’s Jeevan Akshay is an Immediate Annuity plan is a single premium policy. That means the policyholder will have to buy the plan with a lump sum amount, while the annuity is available on a monthly, quarterly, biannually or annually basis.

LIC's Jeevan Akshay Pension Policy With Multiple Annuity Options

Annuity options

There are multiple annuity options available under the LIC Jeevan Akshay policy. According to LIC, the available options have been enlisted below.

Option A: Immediate Annuity for life.
Option B: Immediate Annuity with a guaranteed period of 5 years and life thereafter.
Option C: Immediate Annuity with a guaranteed period of 10 years and life thereafter.
Option D: Immediate Annuity with a guaranteed period of 15 years and life thereafter.
Option E: Immediate Annuity with a guaranteed period of 20 years and life thereafter.
Option F: Immediate Annuity for life with return of Purchase Price.
Option G: Immediate Annuity for life increasing at a simple rate of 3% PA.
Option H: Joint Life Immediate Annuity for life with a provision for 50% of the annuity to the Secondary Annuitant on the death of the Primary Annuitant.
Option I: Joint Life Immediate Annuity for life with a provision for 100% of the annuity payable as long as one of the annuitants survives.
and,
Option J: Joint Life Immediate Annuity for life with a provision for 100% of the annuity payable as long as one of
the Annuitant survives and returns of Purchase Price on the death of the last survivor.

LIC has fixed the Annuity Mode into Monthly, Quarterly, Half-yearly, and Annual modes. The Minimum Annuity is Rs. 1,000 per month, Rs. 3,000 per quarter, Rs. 6,000 per half-year, and Rs. 12,000 per annum.

Benefits of the LIC Jeevan Akshay policy

For Option A

• The annuity payments will be made in arrears till the Annuitant is alive, according to the mode of the annuity payment.
• On the death of the Annuitant, nothing shall be payable and the annuity payment shall cease immediately.

For Option B,C,D,E

• The annuity payments shall be made in arrears for as long as the Annuitant is alive, according to the annuity payment mode.
• On the death of the Annuitant during the guaranteed period of 5/10/15/20 years, the annuity will be paid to the nominee(s) till the guaranteed period.
• On the death of the Annuitant after the guaranteed period, nothing will be paid and the annuity payment will cease immediately.

Option F

• The annuity payments will be paid in arrears for as long as the Annuitant is alive, according to the annuity payment mode.
• On the death of the annuitant, the annuity payment will cease immediately, and Purchase Price will be paid to nominee(s) as per the option chosen by the Annuitant.

Option G

• The annuity payments will be made in arrears for as long as the Annuitant is alive, according to the annuity payment mode. The annuity payment will be increased by a simple rate of 3% PA for each completed policy year.
• On the death of annuitant nothing shall be payable and the annuity payment shall cease immediately.

Option H

• The annuity payments will be paid in arrears till the Primary Annuitant is alive, according to the annuity payment mode.
• On the death of the Primary Annuitant, 50% of the annuity amount will be paid to the surviving Secondary Annuitant till the Secondary Annuitant is alive. The annuity payments will cease on the subsequent death of the Secondary Annuitant.
• If the Secondary Annuitant predeceases the Primary Annuitant, the annuity payments will continue to be paid and will cease upon the death of the Primary Annuitant.

Option I

• 100% of the annuity amount shall be paid in arrears for as long as the Primary Annuitant and/or Secondary Annuitant is alive, according to the annuity payment mode.
• On the death of the last survivor, the annuity payments will cease immediately and nothing will be paid.

Option J

• 100% of the annuity amount will be paid in arrears till the Primary Annuitant and/or Secondary Annuitant is alive, according to the annuity payment mode.
• On the death of the last survivor, the annuity payments will cease immediately, and Purchase Price will be paid to the nominee(s) according to the option exercised by the Primary Annuitant.

Minimum Annuity Chart

Annuity Mode Monthly Quarterly half yearly Annual
Minimum Annuity RS. 1,000 per month RS. 3,000 per quarter RS. 6,000 per half year RS. 12,000 per annum

Source: LIC

Eligibility and minimum purchase

The minimum entry age for the LIC Jeevan Akshay Plan is 30 years, while the maximum entry age is 85 years. However, for the above-mentioned Option F, the maximum entry age can be 100 years.

The Minimum Purchase Price of the plan is Rs. 1,00,000, but this will depend on the Minimum Annuity as specified below. There is no limit on the maximum purchase price.

Story first published: Tuesday, November 2, 2021, 12:44 [IST]



[ad_2]

CLICK HERE TO APPLY

NPA position of Indian Banks indicates gradual improvement: CARE Ratings

[ad_1]

Read More/Less


The non-performing assets (NPA) situation of the Indian banking system as represented by 23 banks — nine public sector banks (PSBs) and 14 private sector banks (PvBs) — that have declared results so far indicates a gradual improvement in the NPA ratio in September 2021, according to an assessment by CARE Ratings.

The Gross NPA (GNPA) ratio of the aforementioned banks has improved to 6.97 per cent as at September-end 2021 against 7.32 per cent as at June-end 2021 and 7.36 per cent as at September-end 2020, the credit rating agency said.

In absolute terms, the GNPA of the banks as at September-end 2021 was at ₹4,53,145 crore (₹4,40,124 crore as at September-end 2020) in a gross advance of ₹64,98,609 crore (₹59,82,606 crore).

Barring State Bank of India, Bank of Baroda and Union Bank of India, most of the other large banks have announced their second quarter financial results, CARE Ratings said.

Improving ratio

The Gross NPA (GNPA) ratio of PSBs has improved to 11.52 per cent as at September-end 2021 against 11.94 per cent as at June-end 2021 and 12.32 per cent as at September-end 2020, according to the agency.

The Gross NPA (GNPA) ratio of PvBs has improved to 3.94 per cent as at September-end 2021 against 4.16 per cent as at June-end 2021 and 3.82 per cent as at September-end 2020.

According to the Reserve Bank of India’s latest Financial Stability Report (July 2021), macro stress tests indicate that the GNPA ratio of scheduled commercial banks (SCBs) may increase from 7.48 per cent in March 2021 to 9.80 per cent by March 2022 under the baseline scenario; and to 11.22 per cent under a severe stress scenario, although SCBs have sufficient capital, both at the aggregate and individual level, even under stress.

[ad_2]

CLICK HERE TO APPLY

1 133 134 135 136 137 16,279